| Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas J Zeng, AP See, J Phallen, CM Jackson, Z Belcaid, J Ruzevick, N Durham, ... International Journal of Radiation Oncology* Biology* Physics 86 (2), 343-349, 2013 | 1029 | 2013 |
| Mechanisms of immunotherapy resistance: lessons from glioblastoma CM Jackson, J Choi, M Lim Nature immunology 20 (9), 1100-1109, 2019 | 537 | 2019 |
| Combination therapy with anti-PD-1, anti-TIM-3, and focal radiation results in regression of murine gliomas JE Kim, MA Patel, A Mangraviti, ES Kim, D Theodros, E Velarde, A Liu, ... Clinical Cancer Research 23 (1), 124-136, 2017 | 438 | 2017 |
| TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM AL Hung, R Maxwell, D Theodros, Z Belcaid, D Mathios, AS Luksik, E Kim, ... Oncoimmunology 7 (8), e1466769, 2018 | 310 | 2018 |
| Anti–PD-1 antitumor immunity is enhanced by local and abrogated by systemic chemotherapy in GBM D Mathios, JE Kim, A Mangraviti, J Phallen, CK Park, CM Jackson, ... Science translational medicine 8 (370), 370ra180-370ra180, 2016 | 280 | 2016 |
| Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model Z Belcaid, JA Phallen, J Zeng, AP See, D Mathios, C Gottschalk, ... PloS one 9 (7), e101764, 2014 | 260 | 2014 |
| Lymphocyte Activation Gene 3 (LAG-3) modulates the ability of CD4 T-cells to be suppressed in vivo NM Durham, CJ Nirschl, CM Jackson, J Elias, CM Kochel, RA Anders, ... PloS one 9 (11), e109080, 2014 | 183 | 2014 |
| Challenges in immunotherapy presented by the glioblastoma multiforme microenvironment C Jackson, J Ruzevick, J Phallen, Z Belcaid, M Lim Journal of Immunology Research 2011 (1), 732413, 2011 | 167 | 2011 |
| STAT3 activation in glioblastoma: biochemical and therapeutic implications JE Kim, M Patel, J Ruzevick, CM Jackson, M Lim Cancers 6 (1), 376-395, 2014 | 132 | 2014 |
| Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment A Wu, R Maxwell, Y Xia, P Cardarelli, M Oyasu, Z Belcaid, E Kim, A Hung, ... Journal of neuro-oncology 143, 241-249, 2019 | 111 | 2019 |
| Immunotherapy for brain cancer: recent progress and future promise CM Jackson, M Lim, CG Drake Clinical Cancer Research 20 (14), 3651-3659, 2014 | 104 | 2014 |
| Clinical trials investigating immune checkpoint blockade in glioblastoma R Maxwell, CM Jackson, M Lim Current treatment options in oncology 18, 1-22, 2017 | 99 | 2017 |
| Deep venous thrombosis and pulmonary embolisms in adult patients undergoing craniotomy for brain tumors KL Chaichana, C Pendleton, C Jackson, JC Martinez-Gutierrez, ... Neurological research 35 (2), 206-211, 2013 | 98 | 2013 |
| Sequencing CTLA-4 blockade with cell-based immunotherapy for prostate cancer S Wada, CM Jackson, K Yoshimura, HR Yen, D Getnet, TJ Harris, ... Journal of translational medicine 11, 1-14, 2013 | 91 | 2013 |
| Trigeminal neuralgia: current approaches and emerging interventions R Xu, ME Xie, CM Jackson Journal of pain research, 3437-3463, 2021 | 79 | 2021 |
| Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma MA Patel, JE Kim, D Theodros, A Tam, E Velarde, CM Kochel, B Francica, ... Journal for immunotherapy of cancer 4, 1-13, 2016 | 78 | 2016 |
| Systemic tolerance mediated by melanoma brain tumors is reversible by radiotherapy and vaccination CM Jackson, CM Kochel, CJ Nirschl, NM Durham, J Ruzevick, A Alme, ... Clinical Cancer Research 22 (5), 1161-1172, 2016 | 72 | 2016 |
| Dendritic cell activation enhances anti-PD-1 mediated immunotherapy against glioblastoma T Garzon-Muvdi, D Theodros, AS Luksik, R Maxwell, E Kim, CM Jackson, ... Oncotarget 9 (29), 20681, 2018 | 70 | 2018 |
| PD-1, PD-L1, PD-L2 expression in the chordoma microenvironment D Mathios, J Ruzevick, CM Jackson, H Xu, S Shah, JM Taube, PC Burger, ... Journal of neuro-oncology 121, 251-259, 2015 | 70 | 2015 |
| Contrasting impact of corticosteroids on anti-PD-1 immunotherapy efficacy for tumor histologies located within or outside the central nervous system R Maxwell, AS Luksik, T Garzon-Muvdi, AL Hung, ES Kim, A Wu, Y Xia, ... Oncoimmunology 7 (12), e1500108, 2018 | 69 | 2018 |
